Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer

Update Il y a 4 ans
Reference: NCT02215876

Woman Man

  • | Country :
  • Singapore
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This is a phase II, single institutional study, to evaluate a novel neo-adjuvant regimen in patients with operable, HER2-negative, breast cancer.


Inclusion criteria

  • Breast Cancer

Links